Security key
74019P207
PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL)
CUSIP: 74019P207
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, $0.000005 par value per share
- Total 13F shares
- 180
- Total 13F value
- $1,415
- Share change
- 0
- SEC-reported price per share
- $7.87
- Number of holders
- 2
- Shares outstanding
- 25,804,443
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
2
Top holders
2
DTIL full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
PRECISION BIOSCIENCES INC SEC filings
PRECISION BIOSCIENCES INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74019P207
Recent filing periods:
Ownership snapshot
Top reported holders of DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Octagon Capital Advisors LP
Disclosed value leader
Octagon Capital Advisors LP
Comparable rows
15/15
Latest evidence
31 Mar 2026
13F
13D/G
3/4/5
Lead comparable stake: 10%
13D/G row: Octagon Capital Advisors LP
Showing 1-6 of 15 holder rows.
Quick read
Octagon Capital Advisors LP leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Octagon Capital Advisors LP's linked filing trail.
Comparable ownership
Top 5
Octagon Capital Advisors LP
10%
Readout Capital, LP
9.4%
Aberdeen Group plc
8.9%
Bleichroeder LP
8.2%
Empery Asset Management, LP
7.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Octagon Capital Advisors LP |
13F
13D/G
Company
|
10%
from 13D/G
|
$12,302,026
2,236,732 shares
|
— | 31 Mar 2026 |
| Readout Capital, LP |
13D/G
Matthew Smith
|
9.4%
|
$4,980,934
1,119,311 shares
|
+$829,645 | 30 Jun 2025 |
| Aberdeen Group plc |
13F
13D/G
Company
|
8.9%
from 13D/G
|
$12,265,979
2,230,178 shares
|
— | 31 Mar 2026 |
| Bleichroeder LP |
13F
13D/G
Company
|
8.2%
from 13D/G
|
$9,143,750
1,662,500 shares
|
— | 31 Mar 2026 |
| Empery Asset Management, LP |
13F
13D/G
Company
|
7.6%
from 13D/G
|
$10,828,835
1,968,879 shares
|
— | 31 Mar 2026 |
| Weinstein Benjamin |
13D/G
|
5.2%
|
$2,107,956
395,489 shares
|
$0 | 18 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
180
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
75
Q2 2026 holders
2
Holder diff
-73
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend